- Home
- COST vs ABBV Comparison
COST vs ABBV Comparison
Compare COST & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COST | ABBV |
|---|---|---|
| Founded | 1976 | 2012 |
| Country | United States | United States |
| Employees | 341000 | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.4B | 400.9B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | COST | ABBV |
|---|---|---|
| Price | $852.98 | $228.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 18 |
| Target Price | ★ $1,051.30 | $242.28 |
| AVG Volume (30 Days) | 3.1M | ★ 6.0M |
| Earning Date | 12-11-2025 | 01-30-2026 |
| Dividend Yield | 0.61% | ★ 3.04% |
| EPS Growth | ★ 9.70 | N/A |
| EPS | ★ 18.67 | 1.32 |
| Revenue | ★ $280,391,000,000.00 | $59,644,000,000.00 |
| Revenue This Year | $9.99 | $10.37 |
| Revenue Next Year | $7.57 | $9.41 |
| P/E Ratio | ★ $45.53 | $172.58 |
| Revenue Growth | ★ 8.34 | 7.40 |
| 52 Week Low | $844.06 | $164.39 |
| 52 Week High | $1,078.24 | $244.81 |
Technical Indicators
Market Signals| Indicator | COST | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 31.78 | 53.07 |
| Support Level | $844.06 | $222.35 |
| Resistance Level | $868.58 | $229.47 |
| Average True Range (ATR) | 14.77 | 4.17 |
| MACD | -2.76 | 0.29 |
| Stochastic Oscillator | 13.76 | 76.10 |
Price Performance
Historical ComparisonAbout COST Costco Wholesale Corporation
Founded in 1983, Costco Wholesale now operates a global chain of membership-based warehouse clubs, delivering high-quality goods and services at consistently low prices. As of its most recent fiscal year, Costco operated approximately 910 warehouses, serving more than 80 million members across its three geographic segments: Costco US (approximately 73% of total revenue), Costco Canada (13%), and Costco International (14%).Costco's core value proposition—quality products at unbeatable prices—has yielded consistently strong member renewal rates (93% in the US and Canada and nearly 90% internationally). About 55% of Costco's fiscal 2025 revenue came from its grocery offerings, and another 25% from general merchandise.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.